{
    "N/R/U": null,
    "Applicant": "Hoffmann-La Roche Inc.",
    "BLA Number": "103749",
    "Proprietary Name": "Zenapax",
    "Proper Name": "daclizumab",
    "BLA Type": "351(a)",
    "Strength": "25MG/5ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "10-Dec-97",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": null,
    "License Number": "136",
    "Product Number": "1",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "daclizumab",
            "drugbank_id": "DB00111"
        }
    ]
}